Press Releases

All Releases
View Summary FDA Modifies Partial Clinical Hold on Tekmira's TKM-Ebola IND to Allow Multiple Dosing of Healthy Volunteers
Apr 10, 2015
PDF 16.3 KB Add to Briefcase
View Summary Tekmira Presents Preclinical Results Demonstrating Super-Additive Effects on Plasma Triglyceride Lowering by Silencing of ApoC3 and ANGPTL3 Genes
Mar 25, 2015
PDF 18.2 KB Add to Briefcase
View Summary Tekmira Announces Completion of Underwritten Public Offering of Common Shares
Mar 25, 2015
PDF 14.3 KB Add to Briefcase
View Summary Tekmira Announces Pricing of Underwritten Public Offering of Common Shares
Mar 20, 2015
PDF 14.7 KB Add to Briefcase
View Summary Tekmira Announces Proposed Public Offering of Common Shares
Mar 18, 2015
PDF 106.7 KB Add to Briefcase
View Summary Tekmira Strengthens Senior Leadership Team With Key Executive Appointments in Corporate Affairs, Chemistry and Biology
Mar 18, 2015
PDF 14.3 KB Add to Briefcase
View Summary Tekmira Provides Corporate Update and Announces Year-End 2014 Results
Mar 12, 2015
PDF 25.4 KB Add to Briefcase
View Summary TKM-Ebola-Guinea Enters Phase II Clinical Study in Sierra Leone
Mar 11, 2015
PDF 17.8 KB Add to Briefcase
View Summary Tekmira to Present at Barclays Global Healthcare Conference
Mar 6, 2015
PDF 9.8 KB Add to Briefcase
View Summary Tekmira Conference Call and Webcast Advisory: Corporate Update and Full Year 2014 Financial Results
Mar 5, 2015
PDF 10.0 KB Add to Briefcase
View Summary Tekmira Announces Completion of the Merger With OnCore Creating a Leading Hepatitis B Solutions Company
Mar 4, 2015
PDF 16.1 KB Add to Briefcase
View Summary 99.5% of Tekmira Shareholders Vote in Favor of Merger
Mar 3, 2015
PDF 12.0 KB Add to Briefcase
View Summary Tekmira Announces Update to Its Proxy Circular on the Proposed Business Combination With OnCore Biopharma Inc.
Feb 25, 2015
PDF 13.2 KB Add to Briefcase
View Summary Tekmira to Present at RBC Capital Markets' Healthcare Conference
Feb 12, 2015
PDF 8.7 KB Add to Briefcase
View Summary Tekmira Announces Filing of Definitive Proxy Statement and Voluntary Delisting From the TSX
Feb 4, 2015
PDF 19.8 KB Add to Briefcase
View Summary Tekmira Initiates Phase I Clinical Trial of TKM-HBV
Jan 21, 2015
PDF 17.6 KB Add to Briefcase
View Summary Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company
Jan 11, 2015
PDF 39.4 KB Add to Briefcase
View Summary Tekmira Provides Update on TKM-PLK1 Phase I/II Clinical Study in Patients With Advanced Gastrointestinal Neuroendocrine Tumors and Adrenocortical Carcinoma
Dec 31, 2014
PDF 60.9 KB Add to Briefcase
View Summary Tekmira Establishes Manufacturing and Clinical Trial Agreement to Provide TKM-Ebola-Guinea for Clinical Studies in West Africa
Dec 22, 2014
PDF 18.6 KB Add to Briefcase
View Summary Tekmira Receives Clearance to Conduct a Phase I Clinical Study With TKM-HBV
Dec 22, 2014
PDF 14.4 KB Add to Briefcase
Showing 1-20 of 268 Page: 1 2 3 4 5 ... 14  Next 20
Add to Briefcase = add release to Briefcase